Education
About Us
Working with TipRanks
Follow Us
FLSW - ETF AI Analysis
Top Page
Franklin FTSE Switzerland ETF (FLSW)
Rating:69Neutral
Price Target:―
Positive Factors
Low Expense Ratio
The ETF charges a relatively low fee, which helps investors keep more of their returns over time.
Strong Core Swiss Holdings
Several major Swiss companies in the top holdings, such as Roche and Novartis, have shown solid recent performance, supporting the fund’s overall results.
Defensive Sector Tilt
Heavy exposure to health care and consumer defensive sectors can help provide some stability during market downturns.
Negative Factors
Country Concentration in Switzerland
Most of the portfolio is invested in Swiss companies, which increases the fund’s sensitivity to economic and market conditions in Switzerland.
Top Holdings Concentration Risk
A small number of large positions make up a significant share of the fund, so weakness in these companies can have an outsized impact on performance.
Mixed Performance Among Key Stocks
Some notable holdings like Nestlé, Richemont, Zurich Insurance, and Swiss Re have shown weaker recent performance, which can drag on the ETF’s overall returns.
FLSW vs. SPDR S&P 500 ETF (SPY)
AUM79.49M
RegionEurope
Expense Ratio0.09%
Beta0.57
IssuerFranklin
Inception DateFeb 06, 2018
Dividend Yield2.11%
Asset ClassEquity
Index TrackedFTSE Switzerland RIC Capped Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume26,022
30 Day Avg. Volume17,704
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
46.37Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering52
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FLSW Summary
The Franklin FTSE Switzerland ETF (FLSW) is a fund that lets you invest in a wide range of Swiss companies by tracking the FTSE Switzerland RIC Capped Index. It holds many types of businesses, including health care, banks, industrial firms, and consumer brands. Well-known holdings include Nestlé, Novartis, and Roche. Someone might invest in this ETF to diversify their portfolio internationally and gain exposure to Switzerland’s stable, high-quality companies in a single investment. A key risk is that the fund is heavily tied to the Swiss market and can go up or down with Swiss and global stock prices.
How much will it cost me?The Franklin FTSE Switzerland ETF (FLSW) has an expense ratio of 0.09%, meaning you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, which typically involves lower costs compared to actively managed funds.
What would affect this ETF?The Franklin FTSE Switzerland ETF could benefit from Switzerland's stable economy and strong performance in sectors like healthcare and consumer defensive, which are less sensitive to economic downturns. However, challenges such as global economic slowdowns, regulatory changes in the pharmaceutical industry, or fluctuations in the financial sector could negatively impact its top holdings and overall performance.
FLSW Top 10 Holdings
This Switzerland-focused ETF leans heavily on healthcare giants Roche and Novartis, which have been steadily rising and doing much of the heavy lifting for performance. Nestlé adds a defensive backbone, chugging along with more modest but reliable gains. Industrial player ABB has been a quiet star, giving the fund an extra boost with strong recent momentum. On the flip side, UBS has been lagging and occasionally pulling on the brakes, while names like Holcim and Lonza show more mixed signals. Overall, it’s a concentrated bet on Swiss blue chips, all anchored firmly in the Swiss market.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Novartis AG | 13.50% | $10.56M | CHF238.47B | 23.59% | 80 Outperform | |
| Roche Holding AG | 13.01% | $10.18M | CHF265.95B | 26.59% | 73 Outperform | |
| Nestlé SA | 11.39% | $8.91M | CHF202.47B | 0.30% | 71 Outperform | |
| ABB Ltd | 6.23% | $4.88M | kr1.40T | 34.87% | 78 Outperform | |
| UBS Group AG | 5.61% | $4.39M | $117.83B | 21.17% | 73 Outperform | |
| Zurich Insurance Group | 4.08% | $3.19M | CHF79.11B | -2.54% | 78 Outperform | |
| Compagnie Financiere Richemont SA | 3.69% | $2.89M | CHF81.00B | -12.87% | 78 Outperform | |
| Swiss Re AG | 2.81% | $2.19M | CHF34.76B | -1.60% | 73 Outperform | |
| Lonza Group Ltd | 2.63% | $2.06M | CHF33.99B | -7.35% | 71 Outperform | |
| Alcon | 2.37% | $1.86M | CHF31.33B | -8.99% | 75 Outperform |
FLSW Technical Analysis
Negative
―
Price Trends
42.89
Negative
41.27
Positive
39.59
Positive
Market Momentum
-0.19
Positive
33.00
Neutral
20.39
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FLSW, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 43.83, equal to the 50-day MA of 42.89, and equal to the 200-day MA of 39.59, indicating a neutral trend. The MACD of -0.19 indicates Positive momentum. The RSI at 33.00 is Neutral, neither overbought nor oversold. The STOCH value of 20.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FLSW.
FLSW Peer Comparison
Comparison Results
Performance Comparison
FLSW
Franklin FTSE Switzerland ETF
41.70
6.34
17.93%
EWL
iShares MSCI Switzerland ETF
―
―
―
EUDG
WisdomTree Europe Quality Dividend Growth Fund
―
―
―
DBEZ
Xtrackers MSCI Eurozone Hedged Equity ETF
―
―
―
FLEU
Franklin FTSE Eurozone ETF
―
―
―
FSZ
First Trust Switzerland AlphaDEX Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents